Part I Basic Pharmacologic Principles |
|
|
1 Pharmacokinetics and Pharmacodynamics of Anesthetics |
|
|
3 | (46) |
|
|
|
2 A Review of Mechanisms of Inhalational Anesthetic Agents |
|
|
49 | (12) |
|
|
3 Pharmacokinetics, Pharmacodynamics, and Physical Properties of Inhalational Agents |
|
|
61 | (12) |
|
|
|
|
4 Principles of Total Intravenous Anesthesia |
|
|
73 | (14) |
|
|
|
5 Perioperative Considerations in Pharmacology |
|
|
87 | (16) |
|
|
|
|
Part II Drug Classes |
|
|
6 Anesthetic Induction Agents |
|
|
103 | (10) |
|
|
|
|
7 Analgesics: Opiate Agonists, Mixed Agonists/Antagonists, and Antagonists for Acute Pain Management |
|
|
113 | (12) |
|
|
|
8 Analgesics: Opioids for Chronic Pain Management and Surgical Considerations |
|
|
125 | (22) |
|
|
|
9 Nonopioid Analgesic and Adjunct Drugs |
|
|
147 | (20) |
|
|
|
|
|
10 Benzodiazepines and Muscle Relaxants |
|
|
167 | (12) |
|
|
|
11 Pharmacology of Local Anesthetics |
|
|
179 | (16) |
|
|
|
12 Neuromuscular Blockers |
|
|
195 | (10) |
|
|
|
|
205 | (14) |
|
|
|
14 Drugs Acting on the Autonomic Nervous System |
|
|
219 | (16) |
|
|
15 Antihypertensives, Diuretics, and Antidysrhythmics |
|
|
235 | (22) |
|
|
16 Peripheral Vasodilators |
|
|
257 | (18) |
|
|
|
17 Nitric Oxide and Pulmonary Vasodilators |
|
|
275 | (20) |
|
|
18 Asthma and COPD Agents |
|
|
295 | (18) |
|
|
|
19 Hormones, Part 1: Thyroid and Corticosteroid Hormones |
|
|
313 | (14) |
|
|
20 Hormones Part 2: Insulin and Other Glucose-Controlling Medications |
|
|
327 | (18) |
|
|
|
|
21 Antacids, Gastrointestinal Prokinetics, and Proton Pump Inhibitors |
|
|
345 | (20) |
|
|
|
|
365 | (16) |
|
|
|
23 Central Nervous System Stimulants |
|
|
381 | (16) |
|
|
|
397 | (18) |
|
|
|
|
|
415 | (6) |
|
|
|
26 Blood, Blood Products, and Substitutes |
|
|
421 | (12) |
|
|
|
|
|
|
27 Antipyretics: Acetathinophen, Arachidonic Acid Agents, and COX1 and COX2 Inhibitors |
|
|
433 | (12) |
|
|
|
|
|
|
445 | (8) |
|
|
|
453 | (32) |
|
|
|
30 Neuropharmacologic Agents for Neurologic Conditions |
|
|
485 | (18) |
|
|
|
31 Chemotherapeutic Agents |
|
|
503 | (22) |
|
|
|
|
|
525 | (24) |
|
|
|
|
33 Herbal Medications and Vitamin Supplements |
|
|
549 | (14) |
|
|
|
|
34 Minerals and Electrolytes |
|
|
563 | (10) |
|
|
|
|
35 Disinfection Agents and Antiseptics |
|
|
573 | (8) |
|
|
|
|
|
36 Psychopharmacologic Agents and Psychiatric Drug Considerations |
|
|
581 | (14) |
|
|
|
|
37 Cocaine, Methamphetamine, MDMA, and Heroin |
|
|
595 | (14) |
|
Part III Clinical Subspecialties |
|
|
|
609 | (36) |
|
|
|
|
|
|
|
39 The Intensive Care Unit |
|
|
645 | (16) |
|
|
|
40 Enteral and Parenteral Nutrition |
|
|
661 | (16) |
|
|
|
|
677 | (20) |
|
|
|
|
|
697 | (10) |
|
|
|
|
|
707 | (12) |
|
|
|
44 Liver Disease and Liver Transplantation |
|
|
719 | (22) |
|
|
Part IV Special Topics |
|
|
45 Black Box FDA Warnings and Legal Implications |
|
|
741 | (12) |
|
|
46 Drug-Induced QT Prolongation |
|
|
753 | (14) |
|
|
|
|
|
47 Drugs and Cancer Propagation |
|
|
767 | (16) |
|
|
|
|
|
783 | (14) |
|
|
|
|
797 | (14) |
|
|
|
|
Part V New Vistas in Pharmacology |
|
|
50 Novel Psychoactive Substances: Synthetic Cathinones and Cannabinoid Receptor Agonists |
|
|
811 | (8) |
|
|
51 New Vistas in Anesthetics, IV Induction Agents |
|
|
819 | (8) |
|
|
52 New Vistas in Neuromuscular Blockers |
|
|
827 | (10) |
|
|
|
53 Patient-Controlled Analgesia: The Importance of Effector Site Pharmacokinetics |
|
|
837 | (10) |
|
|
|
54 Understanding Anesthesia-Induced Memory Loss |
|
|
847 | (12) |
|
|
|
55 Novel Targets of Current Analgesic Drug Development |
|
|
859 | (16) |
|
|
Index |
|
875 | |